InMed Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
31 Jul 24 | SellUS$42 | Alexandra Mancini | Individual | 12 | US$3.53 | |
21 Feb 24 | BuyUS$14,625 | Andrew Hull | Individual | 1,875 | US$7.80 | |
20 Feb 24 | BuyUS$14,922 | Eric Adams | Individual | 2,080 | US$7.17 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 4,115 | 0.573% |
Institutions | 57,099 | 7.95% |
General Public | 656,818 | 91.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 173.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
36,665 | US$165.0k | 0% | 0.03% | |||
10,601 | US$47.7k | 0% | no data | |||
2,833 | US$12.7k | 369% | no data | |||
2,514 | US$11.3k | 0% | no data | |||
2,198 | US$9.9k | 0% | no data | |||
1,918 | US$8.6k | 140% | no data | |||
1,913 | US$8.6k | 0% | no data | |||
1,420 | US$6.4k | -67.2% | no data | |||
1,130 | US$5.1k | 0% | no data | |||
6 | US$27.1 | 0% | no data | |||
5 | US$22.6 | 0% | no data | |||
3 | US$13.6 | 0% | no data | |||
1 | US$4.5 | 0% | no data | |||
1 | US$4.5 | 0% | no data | |||
1 | US$4.5 | 0% | no data | |||
1 | US$4.5 | 0% | no data | |||
1 | US$4.5 | 0% | no data | |||
1 | US$4.5 | 0% | no data | |||
1 | US$4.5 | 0% | no data | |||
1 | US$4.5 | 0% | no data |